Cite
Subramanian S, Costales A, Williams TE, et al. Correction to Design and Synthesis of Orally Bioavailable Benzimidazole Reverse Amides as Pan RAF Kinase Inhibitors. ACS Med Chem Lett. 2014;5(12):1340doi: 10.1021/ml500461g.
Subramanian, S., Costales, A., Williams, T. E., Levine, B., McBride, C. M., Poon, D., Amiri, P., Renhowe, P. A., Shafer, C. M., Stuart, D., Verhagen, J., & Ramurthy, S. (2014). Correction to Design and Synthesis of Orally Bioavailable Benzimidazole Reverse Amides as Pan RAF Kinase Inhibitors. ACS medicinal chemistry letters, 5(12), 1340. https://doi.org/10.1021/ml500461g
Subramanian, Sharadha, et al. "Correction to Design and Synthesis of Orally Bioavailable Benzimidazole Reverse Amides as Pan RAF Kinase Inhibitors." ACS medicinal chemistry letters vol. 5,12 (2014): 1340. doi: https://doi.org/10.1021/ml500461g
Subramanian S, Costales A, Williams TE, Levine B, McBride CM, Poon D, Amiri P, Renhowe PA, Shafer CM, Stuart D, Verhagen J, Ramurthy S. Correction to Design and Synthesis of Orally Bioavailable Benzimidazole Reverse Amides as Pan RAF Kinase Inhibitors. ACS Med Chem Lett. 2014 Nov 25;5(12):1340. doi: 10.1021/ml500461g. eCollection 2014 Dec 11. PMID: 25514817; PMCID: PMC4265813.
Copy
Download .nbib